Article
Characterization of the mutational specificity of DNA cross-linking mutagens by the Lac+ reversion assay with Escherichia coli.
Teratogenesis, carcinogenesis, and mutagenesis - 1 Jan 2001
Ohta T, Ohmae S, Yamaya K, Kanemichi Y, Tokishita S, Yamagata H
Abstract excerpt
The mutational specificities of DNA cross-linking compounds such as cisplatin, transplatin, carboplatin, mitomycin C, psoralen, and 8-methoxypsoralen were investigated in lacZ reversion assay systems of Escherichia coli. Tester strains were constructed by introducing the six kinds of F' plasmids (lacI-, lacZ461, and proAB+), each of which carries a different base-substitution mutation within the lacZ gene. Each...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
